S-Equol: A Novel Therapeutic For HIV-1-Associated Gastrointestinal Dysbiosis
Mason T. Rodriguez, Sarah J. Olmstead, Kristen A. McLaurin, Charles F. Mactutus, Rosemarie M. Booze
This study investigates S-Equol's effect on cocaine-maintained responding in HIV-1 Tg rats, finding microbiome alterations and genotype-specific interactions.
NeuroImmune Pharmacology and Therapeutics · Dec 1, 2025Peer-reviewedNeuroscience